ABSTRACT-The anti-proliferative effects of heparin on subcultured endothelial cells (EC) of rat aorta were investigated to determine whether heparin inhibits the competence phase or the progression phase in the cell cycle using the starting time and the rate of proliferation. Fetal bovine serum (FBS) stimulated EC proliferation increased to 1.5-times in cell number, but decreased to 0.5-times in 3H-thy midine incorporation, compared with the proliferation of rat primary cultured smooth muscle cells (SMC). The FBS-effects on EC proliferation were attributed to the progression phase rather than the competence phase. Heparin (1, 10 or 100pg/ml) significantly inhibited the proliferation of FBS (5%) stimulated EC, and the extent of inhibition was the same in both cell number and 3H-thymidine incor poration. In the 3H-thymidine incorporation every 3 hr, heparin reduced the rate of incorporation into Go-arrested EC, but did not affect the starting time of DNA synthesis. When the index of competence phase, starting time, was plotted against that of progression phase, rate of proliferation, the inhibition of heparin was attributed to the progression phase. These results demonstrate that heparin selectively inhibits the progression phase in subcultured EC of rat aorta.
Heparin not only inhibits blood coagulation but also induces various biological actions. The actions of hepa rin are especially multiple for proliferation of vascular endothelial cells (EC). Heparin potentiates EC pro liferation stimulated by endothelial cell growth factor (1, 2) or stimulates tumor-induced angiogenesis (3) which includes the process of EC proliferation (4) . Heparin also activates various enzymes such as tissue-type plas minogen activator (5) and stimulates migration of capil lary EC (6, 7) . Heparin alone, however, inhibits fetal bovine serum (FBS)-stimulated proliferation of human umbilical cord vein EC and bovine capillary EC (8 10) . The mechanism by which heparin inhibits EC pro liferation has been unclear.
The physiological function of the vessel wall is reg ulated both by vascular smooth muscle cells (SMC) and vascular EC. Angiogenic disease such as diabetic re tinopathy is caused by the aberrant proliferation of EC (4) . Atherosclerosis is caused by the abnormal pro liferation of SMC (11) . However, there are few investiga tions that compared the proliferation between EC and SMC.
Growth-arrested cells in the Go, phase must transit through at least two stages, first competence and then progression, to proliferate (12) . The effects on the competence phase and the progression phase are re flected in the changes of the starting time and the rate of DNA synthesis, respectively (12, 13) . In the present paper, we determined whether heparin inhibited the competence phase or the progression phase of EC pro liferation by monitoring the starting time and the rate of DNA synthesis. Furthermore, the FBS-stimulated proliferation of EC was compared with that of primary SMC of rat aorta.
MATERIALS AND METHODS

Cell culture
Rat aortic EC in primary culture were prepared by the method of Schwartz (14) , with the following modi fications. The thoracic aorta of male Wistar rats (9 week-old, weighing 250-330g) was isolated, and the periadventitial connective tissue was carefully removed. The vessel was placed into a culture dish (100-mm diam eter) filled with 10 ml Hank's balanced salt solution (pH 7.3, 136.8 mM NaCl, 5.4 mM KCI, 0.8 mM MgSO4, 0.4 mM KH2PO4, 1.3 mM CaC12, 0.3 mM Na2HPO4, 5.6 mM glucose and 4.2 mM NaHCO3) and cannulated with a needle. The needle was fastened with a thread, and the other end of the vessel lumen was closed with a vascular clamp. Hank's balanced salt solution containing 2 mg/ml collagenase (Wako, Osaka, Japan) was injected into the vessel from the needle, and the vessel was incubated for 30 min at 37°C. The suspension of EC was centrifuged at 100 X g for 10 min. The pellet was resuspended in Dulbecco's modified Eagle medium (DMEM, Nissui, Tokyo, Japan) which was supplemented with 160 U/ml penicillin G potas sium (Banyu Seiyaku, Tokyo, Japan), 100,ug/ml streptomycin sulfate (Meiji Seika, Tokyo, Japan), 4.2 mM NaHCO3 (complete DMEM) and 20% heat-inacti vated fetal bovine serum (FBS, Whittaker Bioproducts, Walkersville, MD, U.S.A.). The suspension of EC was added into a Type I collagen (Koken, Tokyo, Japan) coated, 24-well plate (Corning, Corning, NY, U.S.A.) at a density of 100 200 cells/0.5 ml/16-mm well. The cells were cultured in a humidified atmosphere of 5% CO2 in air at 37°C. The non-endothelial cells such as SMC and fibroblasts were detached from the culture dish with a rubber cleaner (Ikemoto Scientific Technol ogy, Tokyo, Japan) under an optical microscope. The detached cells were removed by medium exchange. This cloning procedure was repeated until EC colonies with no non-endothelial cells were obtained. The cloned EC were passaged at a split ratio of 1 : 2 or 1 : 4 by treatment with Ca t+ and Mg2+-free phosphate buffered saline containing 0.5 mg/ml trypsin (Difco, Detroit, MN, U.S.A.) and 0.54 mM EDTA•2Na. Sub cultured EC between the 6th and 9th passage were used in the proliferation assay. EC were identified with their typical cobblestone-like morphology and the abil ity for tube-like formation in vitro (15) .
Primary cultured SMC of male Wistar strain rats (9 week-old, weighing 222 300 g) were isolated, cultured and characterized as previously described (13) .
Assay of cell number counting
The cell number was measured daily until the culture reached confluence as follows. Subcultured EC or primary cultured SMC were resuspended in complete DMEM containing various concentrations of FBS and seeded at a density of 3.0 X 104 cells/16-mm well into a 24-well plate. Heparin (Sigma, St. Louis, MO, U.S.A.) was dissolved in Ca t+ and Mg2+-free phosphate-buffered saline and added into the medium (the final concentration of solvent < 0.1%) in some ex periments. The fresh culture medium with or without heparin was exchanged every other day. At the indi cated day, the culture medium was aspirated, and cells were trypsinized and harvested into a tube containing 0.5 ml complete DMEM with 10% FBS. The cell num ber was counted using a hemocytometer (Nitirin, Tokyo, Japan). Cell viability was confirmed by not staining with trypan blue (Wako).
Assay of DNA synthesis every day in 10-day culture Subcultured EC or primary cultured SMC (3.0 X 104 cells/16-mm well) were cultured for various periods in complete DMEM with 5% or 10% FBS. Heparin was simultaneously added into the medium in some experi ments. The culture medium was removed every 24 hr from 2 or 3 wells, and the cells were washed with complete DMEM. After complete DMEM (0.5 ml) with 0.037 MBq [meth yl-3H]-thymidine (925 GBq/mmol, Amersham Japan, Tokyo, Japan) was added to each well, the incubation was carried out for 2 hr at 37°C (pulse labeling). Then the radioactivity was counted with a scintillation spectrometer (LS3801, Beckman, Clifton, U.S.A.) as described (13) . Total incorporation of 3H-thymidine on a given day was represented as fol lows: 24 (hr) X 1/2 X [(dpm of the radioactivity per hr on the previous day) + (dpm of the radioactivity per hr on a given day)]. The tritium-thymidine incorpora tion during 10 days was estimated as the cumulative sum of incorporation on each day.
Assay of DNA synthesis every 3-hr interval Subcultured EC (3.0 X 104 cells/16-mm well) were cultured with 5% FBS-complete DMEM for 6 days to obtain a nearly confluent growth, and then synchro nized at the Go phase by removing serum for 2 days. The culture medium was exchanged with 5% FBS-com plete DMEM containing 0.037 MBq 3H-thymidine in the presence or absence of heparin. The cells were in cubated at 37°C for the indicated periods (continuous labeling). The radioactivity of labeled cells was meas ured every 3-hr interval from the 9-hr culture time.
Statistical analyses
Data were calculated by two-way analysis of variance (ANOVA), and significant differences were judged by the multiple range test of Tukey at P = 0.05 or P = 0.01.
RESULTS
FBS concentration-dependently stimulated the prolifera tion of subcultured EC compared with primary cultured SMC of rat aorta
We compared the FBS-stimulated growth sensitivity to EC with that to SMC of rat aorta using the cell number and 3H-thymidine incorporation (Figs. 1 and 2). As assessed by both growth indices, FBS stimulated EC and SMC proliferation in a concentration-depend ent manner. EC and SMC showed the maximal proli ferative effects stimulated by 10% FBS. The prolifer ative rate of EC was greater than that of SMC in cell number (Fig. 1, a and b) ; the population doubling time of logarithmically proliferating cells was 25.6 hr (EC) versus 29.1 hr (SMC), and the cell density in the con fluent state was 13.6 X 104 cells/cm2 (EC) versus 9.0 X 104 cells/cm2 (SMC). Tritium-thymidine incorpora tion into EC, however, was under half of that into SMC (Fig. 2, a and b) . The total 3H-thymidine incor poration into EC was not saturated, although the cell number of EC reached a plateau phase up to 10-day culture. EC also held the same growth response to FBS until 10 passages (data not shown). Heparin inhibited FBS-stimulated proliferation of sub cultured EC of rat aorta Heparin (1 mg/ml) significantly inhibited the cell number of non-synchronized EC not depending on the FBS concentration supplemented in the growth medium. The percent inhibition of heparin at 5-day culture was 20.6% (5% FBS), 40.0% (10% FBS) and 31.6% (20% FBS) for the control without heparin, respectively. To accurately determine the anti-proliferative effects of heparin, we further used synchronized EC. EC were arrested at the Go phase by removing FBS (serum starvation) for 2 days. Heparin (10 or 100 lug/ml) concentration-dependently decreased the cell number and the total 3H-thymidine incorporation of EC stimu lated by 5% FBS (Fig. 3, a and b) . Heparin (100 ,ug/ml) showed almost the same inhibitory percentage in both cell number (25.4%) and 3H-thymidine incor poration (28.5%) for the control without heparin in 10 day culture.
To elucidate the effects of heparin on the transition of cell cycle from the Go to the S phase, we measured 3H -thymidine incorporation every 3 hr . After the syn chronization at the Go phase, EC were stimulated by 5% FBS with or without heparin. The FBS-stimulated EC initiated 3H-thymidine incorporation from 18 hr in the control medium without heparin (Fig. 4) . EC which were stimulated by 10% FBS also showed the same ex tent of proliferation (data not shown). These results demonstrated that the length of the Go/G1 phase in the EC cell cycle was 18 hr. Heparin ('1, 10 or 100,ug/ ml) concentration-dependently reduced the rate of 3H-thy midine incorporation into the FBS-stimulated EC with out affecting the starting time of DNA synthesis. Fig. 3 . Anti-proliferative effects of heparin (1, 10 or 100,ug/ml) in cell number (a) and 3H-thymidine incorporation (b) of EC synchronized at the Go phase. Subcultured EC were synchronized for 2 days by serum starvation and then stimulated by 5% FBS in the presence or absence of heparin. The cell number and the 3H-thymidine incorporation were measured every day as described in Materials and Methods. The values represent the means ± S.E.M. of 3 experiments. a) *P < 0.05; * *P < 0.01 (compared to the control without heparin). b) The significant differences for the control without heparin at P < 0.05 (on day 3: 100,ug/ml heparin) and P < 0.01 (on days 4, 5, 7, 8, 9 and 10: 1, 10 and 100 mg/ml and on day 6: 1 and 100,ug/ml heparin). Fig. 4 . Effects of heparin (1, 10 or 100 ,ug/ml) on the Go-S tran sition of the EC cell cycle. Subconfluent EC (cultured 6 days) were synchronized for 2 days by serum starvation and then stimu lated by 5% FBS and 3H-thymidine with or without heparin. Tritium-thymidine incorporation was measured at every 3-hr inter val as described in Materials and Methods. The values represent the means ± S.E.M. of 3 experiments. * P < 0.05, * * P < 0.01 (compared to the control without heparin).
Contribution of the anti-proliferative effects of heparin on EC cell cycle
The effects of heparin on the competence phase and the progression phase of the cell cycle are estimated with the starting time and the rate of proliferation, re spectively (12, 13) . From the growth curves in Fig. 4 , we conveniently estimated the anti-proliferative effects by (Ct Cc)/Cc, an index of competence, and (Pt Pc)/Pc, an index of progression. Ct or Cc was the starting time of proliferation with or without heparin.
Pt or Pc was the doubling time of cell number with or without heparin which was calculated from a starting time of cell growth. The (Ct Cc)/Cc was plotted against the (Pt Pc)/Pc (Fig. 5) . The contribution of FBS to EC proliferation was also plotted as a standard proliferation line.
The effects of FBS on EC proliferation were due to the progression phase rather than to the competence phase. The anti-proliferative effects of heparin on EC were preferentially attributable to the inhibition of the progression phase rather than the competence phase (Fig. 5) . 
DISCUSSION
Heparin inhibits proliferation of various types of cells, but the mechanisms have not been well-under stood. Heparin concentration-dependently reduced the rate of 3H-thymidine incorporation into the FBS-stimu lated EC, but did not affect the starting time of DNA synthesis. In the present study, we tried to classify the inhibitory effects of heparin on EC proliferation into two phases as proposed by Pledges et al. (12) , compe tence and progression, using a convenient assay. In a growth curve against cultured time, the starting time and the rate of proliferation reflect the effects of com petence and progression in the cell cycle, respectively (12, 13) . If a growth inhibitor affects only the compe tence phase (Go/G,) in the cell cycle, it prolongs the starting time of proliferation, (Ct Cc) (16) . If a growth inhibitor affects only the progression phase (Gi/S) in the cell cycle, it changes the doubling time of cell number, (Pt Pc) (17) . Therefore, we estimated the relative indices: (Ct Cc)/Cc and (Pt Pc)/Pc. When the index of the competence phase, (Ct Cc)/Cc, was plotted against the index of the progres sion phase, (Pt Pc)/Pc, the slope of the regression line for inhibition by heparin was increased towards the Y axis, (Pt Pc)/Pc. This result shows that the anti proliferative effects of heparin on EC are attributable to the inhibition of the progression phase. Heparin easily binds many growth factors and nutrients. However, the inhibition by heparin of the progression phase is not due to competitive inhibition of the bind ing of progression factors in serum because high FBS concentrations (10% or 20%) did not abolish the effects of heparin on EC proliferation. Similar results have been reported for bovine aortic SMC (18) . Heparin binds to the surface of EC and is internalized into the cell (19) . SMC also possess the specific high affinity receptor for heparin and internalize the heparin into the cell (20) . We have already reported that heparin does not affect the PDGF-induced compe tence, but blocks the FBS-induced progression phase of SMC proliferation in rat aorta (13) . These results sug gest that heparin inhibits the progression phase of both EC and SMC proliferation through the common intra cellular pathway.
Heparin shows the anti-proliferative effects on SMC to a greater extent than on EC (21, 22) . Heparin sup presses the expression of c-myb proto-oncogene, which induces the progression from the G, phase to the S phase (23, 24) , in vascular SMC (25) . Heparin also in hibits a protein kinase C-dependent pathway for induc tion of c fos and c-myc mRNA expression in rat SMC (26, 27) . However, the mechanisms by which heparin inhibits the progression phase in EC proliferation re mains unknown.
Although most of the actions of heparin on SMC proliferation leads growth arrest (28) , heparin possesses multiple functions in EC proliferation; heparin alone inhibits EC proliferation, but potentiates the mitogenic activity of endothelial cell growth factor administered simultaneously (1, 2) . Heparin stimulates the release of non-PDGF-like endothelial cell-derived growth fac tors from confluently cultured bovine EC (29) . These growth factors stimulate EC and SMC prolifera tion. Vascular EC and SMC also produce a heparin like molecule (21, 30) . Heparin may be an important regulator of EC proliferation as well as SMC prolifera tion.
FBS possesses both competence and progression activity on BALB/c 3T3 cells because it contains many kinds of growth factors and hormone (31) . For EC, however, it has been unclear how much competence activity and how much progression activity contributes to the proliferative activity of FBS. In the present study, the effects of FBS were attributed to the pro gression phase rather than the competence phase. When the growth property of EC was compared with that of SMC from rat aorta, FBS showed greater sensitivity to EC than to SMC in the index of cell number. The pro liferative property of EC with FBS was consistent with the previous report using EC of rat aorta (32) . Total 3H -thymidine incorporation into EC , however, was less than half that into SMC. Human recombinant platelet derived growth factor also did not increase FBS-stimu lated EC proliferation (data not shown), but potenti ated FBS-stimulated SMC proliferation (13) . The dif ferent efficiencies of FBS and other growth factors be tween EC and SMC proliferation may be very impor tant to maintain the properties of blood vessels in vivo.
In conclusion, we found that heparin inhibited the FBS-stimulated progression phase in the proliferation of subcultured EC of rat aorta. Subcultured EC and primary cultured SMC were demonstrated to have different efficiencies of proliferation in response to FBS in terms of the index of cell number or 3H-thymi dine incorporation.
